Hansa Biopharma to participate in Jefferies Global Healthcare Conference in London
Lund, Sweden, November 10, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, will participate in a fireside chat with Farzin Haque, Biotechnology Equity Research Analyst, Jefferies, at the Jefferies Global Healthcare Conference in London, on Tuesday 17 November, at 14:00-14:25 GMT / 09:00-09:25 EST. Hansa Biopharma COO and President US Maria Törnsén, CFO Adam Cutler, CMO Richard Philipson, and VP Business Development Fredrik Röök will also be attending the event.
